Published in Nat Chem Biol on October 10, 2010
Full antagonism of the estrogen receptor without a prototypical ligand side chain. Nat Chem Biol (2016) 2.05
Inhibition of α-helix-mediated protein-protein interactions using designed molecules. Nat Chem (2013) 2.02
A unified view of "how allostery works". PLoS Comput Biol (2014) 1.59
Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov (2011) 1.39
Structural and mechanistic insights into bisphenols action provide guidelines for risk assessment and discovery of bisphenol A substitutes. Proc Natl Acad Sci U S A (2012) 1.26
Ligand and receptor dynamics contribute to the mechanism of graded PPARγ agonism. Structure (2012) 1.21
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network. Elife (2014) 1.07
Research resource: Transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM/estrogen complexes. Mol Endocrinol (2012) 1.04
Multi-species analyses of direct activators of the constitutive androstane receptor. Toxicol Sci (2011) 1.00
Ligand-binding dynamics rewire cellular signaling via estrogen receptor-α. Nat Chem Biol (2013) 0.96
Structural and functional profiling of environmental ligands for estrogen receptors. Environ Health Perspect (2014) 0.90
Towards structural systems pharmacology to study complex diseases and personalized medicine. PLoS Comput Biol (2014) 0.87
Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery. Mol Pharmacol (2012) 0.87
Improved crystallographic structures using extensive combinatorial refinement. Structure (2013) 0.87
Structural mechanisms of allostery and autoinhibition in JNK family kinases. Structure (2012) 0.86
Predictive features of ligand-specific signaling through the estrogen receptor. Mol Syst Biol (2016) 0.85
From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). Steroids (2014) 0.84
The designability of protein switches by chemical rescue of structure: mechanisms of inactivation and reactivation. J Am Chem Soc (2013) 0.84
Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists. BMC Bioinformatics (2014) 0.84
Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Nat Commun (2015) 0.83
Direct detection of structurally resolved dynamics in a multiconformation receptor-ligand complex. J Am Chem Soc (2011) 0.83
Cell development obeys maximum Fisher information. Front Biosci (Elite Ed) (2013) 0.82
Versatility or promiscuity: the estrogen receptors, control of ligand selectivity and an update on subtype selective ligands. Int J Environ Res Public Health (2014) 0.81
Ultrafast protein structure-based virtual screening with Panther. J Comput Aided Mol Des (2015) 0.79
VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res (2014) 0.78
LIBSA--a method for the determination of ligand-binding preference to allosteric sites on receptor ensembles. J Chem Inf Model (2014) 0.78
Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer. J Med Chem (2015) 0.77
Concerted dynamic motions of an FABP4 model and its ligands revealed by microsecond molecular dynamics simulations. Biochemistry (2014) 0.77
Structural and Molecular Mechanisms of Cytokine-Mediated Endocrine Resistance in Human Breast Cancer Cells. Mol Cell (2017) 0.76
Alkaloids as inhibitors of malate synthase from Paracoccidioides spp.: receptor-ligand interaction-based virtual screening and molecular docking studies, antifungal activity, and the adhesion process. Antimicrob Agents Chemother (2015) 0.75
Ligand Binding Ensembles Determine Graded Agonist Efficacies at a G Protein-coupled Receptor. J Biol Chem (2016) 0.75
Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions? Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Flexible Small Molecular Anti-estrogens with N,N-dialkylated-2,5-diethoxy-4-morpholinoaniline scaffold Targets Multiple Estrogen Receptor Conformations. Cell Cycle (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr (2002) 53.61
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr (2006) 14.21
Theory of protein folding: the energy landscape perspective. Annu Rev Phys Chem (1997) 10.65
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96
Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science (2000) 9.29
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Intrinsic dynamics of an enzyme underlies catalysis. Nature (2005) 7.32
The CCP4 molecular-graphics project. Acta Crystallogr D Biol Crystallogr (2002) 7.15
Two-state allosteric behavior in a single-domain signaling protein. Science (2001) 6.07
Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science (1990) 5.76
A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site. Protein Expr Purif (2002) 5.72
Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell (2003) 5.44
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature (1995) 4.79
Dynamically driven protein allostery. Nat Struct Mol Biol (2006) 4.53
Structural evidence for feedback activation by Ras.GTP of the Ras-specific nucleotide exchange factor SOS. Cell (2003) 3.66
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature (2002) 3.11
An NMR perspective on enzyme dynamics. Chem Rev (2006) 3.11
LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol (2006) 3.11
Ligand binding and internal equilibria in proteins. Biochemistry (1972) 2.97
Partial agonists activate PPARgamma using a helix 12 independent mechanism. Structure (2007) 2.57
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol (2008) 2.44
Structural analysis of autoinhibition in the Ras activator Son of sevenless. Cell (2004) 2.38
Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol (1996) 1.99
The linkage between protein folding and functional cooperativity: two sides of the same coin? Annu Rev Biophys Biomol Struct (2001) 1.90
c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. Structure (2007) 1.87
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol (2002) 1.83
Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc Natl Acad Sci U S A (2003) 1.71
A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase. J Biol Chem (2004) 1.55
Visualizing polynucleotide polymerase machines at work. EMBO J (2006) 1.52
Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. Proc Natl Acad Sci U S A (2005) 1.50
Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep (2007) 1.47
A solution NMR study showing that active site ligands and nucleotides directly perturb the allosteric equilibrium in aspartate transcarbamoylase. Proc Natl Acad Sci U S A (2007) 1.46
Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Curr Opin Chem Biol (2008) 1.39
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. Chem Biol (2007) 1.31
Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism. Proc Soc Exp Biol Med (1998) 1.20
Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell (2004) 1.11
The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12. J Biol Chem (2002) 1.08
Molecular basis of selective PPARgamma modulation for the treatment of Type 2 diabetes. Biochim Biophys Acta (2007) 1.06
Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia. J Med Chem (2006) 1.04
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis. J Med Chem (2004) 1.03
Nucleotide switches in molecular motors: structural analysis of kinesins and myosins. Curr Opin Struct Biol (2001) 1.03
A natural product ligand of the oxysterol receptor, liver X receptor. J Pharmacol Exp Ther (2003) 0.98
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes. Bioorg Med Chem Lett (2008) 0.97
Comparison of reporter gene assay and immature rat uterotrophic assay of twenty-three chemicals. Toxicology (2002) 0.84
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr (2012) 11.31
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr (2007) 7.72
Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr D Biol Crystallogr (2009) 6.47
Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell (2004) 5.94
Structural basis for double-stranded RNA processing by Dicer. Science (2006) 5.86
Automated structure solution with the PHENIX suite. Methods Mol Biol (2008) 5.65
Automated ligand fitting by core-fragment fitting and extension into density. Acta Crystallogr D Biol Crystallogr (2006) 5.03
Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol (2002) 5.01
electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr D Biol Crystallogr (2009) 4.90
A robust bulk-solvent correction and anisotropic scaling procedure. Acta Crystallogr D Biol Crystallogr (2005) 4.82
SPARX, a new environment for Cryo-EM image processing. J Struct Biol (2006) 4.66
Surprises and pitfalls arising from (pseudo)symmetry. Acta Crystallogr D Biol Crystallogr (2007) 4.44
Recent developments in phasing and structure refinement for macromolecular crystallography. Curr Opin Struct Biol (2009) 4.09
An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell (2011) 4.04
The Phenix software for automated determination of macromolecular structures. Methods (2011) 3.81
Generalized X-ray and neutron crystallographic analysis: more accurate and complete structures for biological macromolecules. Acta Crystallogr D Biol Crystallogr (2009) 3.69
Averaged kick maps: less noise, more signal... and probably less bias. Acta Crystallogr D Biol Crystallogr (2009) 3.62
Simultaneous femtosecond X-ray spectroscopy and diffraction of photosystem II at room temperature. Science (2013) 3.60
Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol (2004) 3.55
Robust indexing for automatic data collection. J Appl Crystallogr (2004) 3.51
Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina (2013) 3.42
A new generation of crystallographic validation tools for the protein data bank. Structure (2011) 3.41
Controlling cell behavior electrically: current views and future potential. Physiol Rev (2005) 3.34
Crystallographic model quality at a glance. Acta Crystallogr D Biol Crystallogr (2009) 3.11
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope. J Clin Invest (2008) 3.11
Identification of multivesicular bodies as prevacuolar compartments in Nicotiana tabacum BY-2 cells. Plant Cell (2004) 3.08
Iterative-build OMIT maps: map improvement by iterative model building and refinement without model bias. Acta Crystallogr D Biol Crystallogr (2008) 3.07
Interpretation of ensembles created by multiple iterative rebuilding of macromolecular models. Acta Crystallogr D Biol Crystallogr (2007) 3.07
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol (2003) 3.06
Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science (2013) 2.95
Ligand identification using electron-density map correlations. Acta Crystallogr D Biol Crystallogr (2006) 2.82
On macromolecular refinement at subatomic resolution with interatomic scatterers. Acta Crystallogr D Biol Crystallogr (2007) 2.75
Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Mol Cell Biol (2004) 2.71
Automatic multiple-zone rigid-body refinement with a large convergence radius. J Appl Crystallogr (2009) 2.66
Partial agonists activate PPARgamma using a helix 12 independent mechanism. Structure (2007) 2.57
NFkappaB selectivity of estrogen receptor ligands revealed by comparative crystallographic analyses. Nat Chem Biol (2008) 2.44
Room temperature femtosecond X-ray diffraction of photosystem II microcrystals. Proc Natl Acad Sci U S A (2012) 2.43
The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature (2008) 2.43
Nanoflow electrospinning serial femtosecond crystallography. Acta Crystallogr D Biol Crystallogr (2012) 2.32
Estrogen dendrimer conjugates that preferentially activate extranuclear, nongenomic versus genomic pathways of estrogen action. Mol Endocrinol (2005) 2.30
An analysis of the indications for cesarean section in a teaching hospital in China. Eur J Obstet Gynecol Reprod Biol (2013) 2.26
Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol (2003) 2.17
International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev (2006) 2.15
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res (2005) 2.14
Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol (2008) 2.09
Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives. BMC Bioinformatics (2013) 2.07
The protein structure initiative structural genomics knowledgebase. Nucleic Acids Res (2008) 2.03
Crystal structure of a bacterial ribonuclease P RNA. Proc Natl Acad Sci U S A (2005) 2.01
Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons. Nat Cell Biol (2004) 1.96
Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem (2006) 1.91
Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest (2010) 1.90
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res (2006) 1.90
Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol (2002) 1.83
Joint X-ray and neutron refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr (2010) 1.80
Role of the gamma-phosphate of ATP in triggering protein folding by GroEL-GroES: function, structure and energetics. EMBO J (2003) 1.78
Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology (2002) 1.74
The efficiency of protein compartmentalization into the secretory pathway. Mol Biol Cell (2004) 1.74
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer. Breast Cancer Res Treat (2008) 1.72
Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator. Proc Natl Acad Sci U S A (2005) 1.72
Antagonists selective for estrogen receptor alpha. Endocrinology (2002) 1.70
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol (2008) 1.70
Rha1, an Arabidopsis Rab5 homolog, plays a critical role in the vacuolar trafficking of soluble cargo proteins. Plant Cell (2003) 1.67
Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg Med Chem (2004) 1.67
Structure of a three-domain sesquiterpene synthase: a prospective target for advanced biofuels production. Structure (2011) 1.67
Use of knowledge-based restraints in phenix.refine to improve macromolecular refinement at low resolution. Acta Crystallogr D Biol Crystallogr (2012) 1.64
Application of direct current electric fields to cells and tissues in vitro and modulation of wound electric field in vivo. Nat Protoc (2007) 1.62
Modelling dynamics in protein crystal structures by ensemble refinement. Elife (2012) 1.62
AutismKB: an evidence-based knowledgebase of autism genetics. Nucleic Acids Res (2011) 1.59
Exploring the structural dynamics of the E.coli chaperonin GroEL using translation-libration-screw crystallographic refinement of intermediate states. J Mol Biol (2004) 1.56
Crystal structure of DNA sequence specificity subunit of a type I restriction-modification enzyme and its functional implications. Proc Natl Acad Sci U S A (2005) 1.54
Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer (2006) 1.54
Estrogen receptor dimerization: ligand binding regulates dimer affinity and dimer dissociation rate. Mol Endocrinol (2002) 1.53
phenix.mr_rosetta: molecular replacement and model rebuilding with Phenix and Rosetta. J Struct Funct Genomics (2012) 1.53
Biomedicine. Defining the "S" in SERMs. Science (2002) 1.52
Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur J Nucl Med Mol Imaging (2005) 1.52
Electrical cues regulate the orientation and frequency of cell division and the rate of wound healing in vivo. Proc Natl Acad Sci U S A (2002) 1.52
Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding. J Med Chem (2004) 1.50
Non-invasive measurement of bioelectric currents with a vibrating probe. Nat Protoc (2007) 1.48
Wound healing in rat cornea: the role of electric currents. FASEB J (2005) 1.48
Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res (2013) 1.47
Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains. Mol Endocrinol (2003) 1.47
Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep (2007) 1.47
The multifunctional human p100 protein 'hooks' methylated ligands. Nat Struct Mol Biol (2007) 1.46